Predicting severe outcomes in acute pancreatitis

Acute pancreatitis (AP) is among the most complex inflammatory illnesses, with its incidence rising due to heightened stress, particularly from warfare. In fact, the severity prognosis, especially the severe (S) course in AP (SAP) in the early hours, is essential, as it considerably determines the patient’s treatment options. Although there are various clinical, biochemical, and imaging criteria for determining the severity of AP, each scoring system has distinct limitations, as it is time-consuming because it requires evaluating approximately 10 parameters. This study presents a developed prognostic criterion (PC) that provides rapid prediction of the SAP, as it is based on the evaluation of just two parameters. The PC is calculated as the ratio of the urine urea concentration, measured by a proposed amperometric biosensor, to the serum urea concentration. The findings indicate that a PC value between 60 and 15 suggests a mild or moderate-severe course. Conversely, a PC value below 15 predicts a S course or potential lethal outcome (LO). The PC shows exceptional diagnostic accuracy in differentiating S/LO from healthy controls, yielding an area under the curve of 0.969 (95% CI: 0.924–0.998). At an optimal cutoff of ≤ 19.55, the PC yields 88.0% sensitivity and a perfect specificity of 100.0%. This PC offers a simple, personalized tool for physicians to identify high-risk patients and optimize treatment to reduce mortality. The proposed amperometric urea biosensor demonstrates reliable performance in raw urine, providing a practical solution for rapid clinical assessment. Overall, this represents a foundational step toward the development of non-invasive point-of-care diagnostics and prognostics, especially in resource-limited settings, such as Ukraine and neighboring countries currently providing care to refugees. A simple-to-operate amperometric biosensor with reliable performance in biological samples is proposed for PC determination.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-12
DOI
https://doi.org/10.3389/fphar.2026.1946528
Primary Topic
Pancreatitis Pathology and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Predicting severe outcomes in acute pancreatitis

Ieva Šakinytė, Vidutė Gurevičienė, Julija Razumienė
Frontiers in Pharmacology
Pancreatitis Pathology and Treatment
article

Predicting severe outcomes in acute pancreatitis

Ieva Šakinytė, Vidutė Gurevičienė, Julija Razumienė
article en

Abstract

Acute pancreatitis (AP) is among the most complex inflammatory illnesses, with its incidence rising due to heightened stress, particularly from warfare. In fact, the severity prognosis, especially the severe (S) course in AP (SAP) in the early hours, is essential, as it considerably determines the patient’s treatment options. Although there are various clinical, biochemical, and imaging criteria for determining the severity of AP, each scoring system has distinct limitations, as it is time-consuming because it requires evaluating approximately 10 parameters. This study presents a developed prognostic criterion (PC) that provides rapid prediction of the SAP, as it is based on the evaluation of just two parameters. The PC is calculated as the ratio of the urine urea concentration, measured by a proposed amperometric biosensor, to the serum urea concentration. The findings indicate that a PC value between 60 and 15 suggests a mild or moderate-severe course. Conversely, a PC value below 15 predicts a S course or potential lethal outcome (LO). The PC shows exceptional diagnostic accuracy in differentiating S/LO from healthy controls, yielding an area under the curve of 0.969 (95% CI: 0.924–0.998). At an optimal cutoff of ≤ 19.55, the PC yields 88.0% sensitivity and a perfect specificity of 100.0%. This PC offers a simple, personalized tool for physicians to identify high-risk patients and optimize treatment to reduce mortality. The proposed amperometric urea biosensor demonstrates reliable performance in raw urine, providing a practical solution for rapid clinical assessment. Overall, this represents a foundational step toward the development of non-invasive point-of-care diagnostics and prognostics, especially in resource-limited settings, such as Ukraine and neighboring countries currently providing care to refugees. A simple-to-operate amperometric biosensor with reliable performance in biological samples is proposed for PC determination.

Frontiers in PharmacologyVol. 17
Vilnius University (LT)
Good health and well-being
Pancreatitis Pathology and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon